Patients and Therapy

  • Ursula Creutzig
  • Jörg Ritter
  • Günther Schellong


The investigations are based on the pre- and post-therapeutic data from 333 study patients. The following criteria of patient eligibility were applied:
  1. 1.

    Primary diagnosis of AML between December 1, 1978, and September 30,1982, in study AML-BFM-78 and between December 1,1982, and September 30, 1986, in study AML-BFM-83

  2. 2.

    Age between 0 and 17 years

  3. 3.

    Prior cytotoxic treatment not exceeding two weeks



Initial Therapy Cranial Irradiation Cytosine Arabinoside Consolidation Therapy Bone Marrow Aplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Ursula Creutzig
    • 1
  • Jörg Ritter
  • Günther Schellong
  1. 1.Universitäts-KinderklinikMünsterGermany

Personalised recommendations